We recommend repeating cardiac biomarkers (troponin and BNP/NT-proBNP) every 3–6 months in all patients with EGPA (Fig. 8) and this may be more frequent in those with cardiac disease depending on the clinical context. Here, NPPB is linked to heart disorder.